Review Article
Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC
Table 4
Results for RFA for HCC.
| Author | Year | Number of patients | Inclusion criteria if any | 3-year survival (%) | 5-year survival (%) |
| Chen et al. [58] | 2006 | 71 | Solitary <5 cm | 71 | 68a | Livraghi et al. [59] | 2008 | 218 | Solitary <2 cm | 76 | 55b | N’Kontchou et al. [60] | 2009 | 222 | Up to 3 HCC <5 cm | | 40c | Peng et al. [62] | 2010 | 224 | Solitary <5 cm | | 60 | Huang et al. [63] | 2010 | 115 | Milan | 70 | 55 |
|
|
a4-year survival.
bSurvival increased to 69% for “operable” patients.
cSurvival increased to 76% for “operable” patients.
|